The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 1, 2024 | Pfizer Inc | Insider | Tender(U) | 27.3M | $45.00 | $1.2B |
| Aug 1, 2024 | Mckernan Ruth | Director | Disposed to issuer(D) | 93K | — | — |
| Aug 1, 2024 | Burgess Paul D. | See Remarks | Disposed to issuer(D) | 46K | — | — |
| Aug 1, 2024 | Burgess Paul D. | See Remarks | Disposed to issuer(D) | 96K | — | — |
| Aug 1, 2024 | Burgess Paul D. | See Remarks | Disposed to issuer(D) | 81K | — | $0 |
| Aug 1, 2024 | Coles N Anthony | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Coles N Anthony | Director | Disposed to issuer(D) | 16K | — | — |
| Aug 1, 2024 | Coles N Anthony | Director | Disposed to issuer(D) | 4.8M | — | — |
| Aug 1, 2024 | Coles N Anthony | Director | Disposed to issuer(D) | 46K | — | $0 |
| Aug 1, 2024 | Patrick Deval L | Director | Disposed to issuer(D) | 3K | — | — |
| Aug 1, 2024 | Patrick Deval L | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Patrick Deval L | Director | Disposed to issuer(D) | 50K | — | — |
| Aug 1, 2024 | Bodenrader Mark | See Remarks | Disposed to issuer(D) | 18K | — | — |
| Aug 1, 2024 | Bodenrader Mark | See Remarks | Disposed to issuer(D) | 278K | — | — |
| Aug 1, 2024 | Bodenrader Mark | See Remarks | Disposed to issuer(D) | 25K | — | $0 |
| Aug 1, 2024 | Riedel Norbert G | Director | Disposed to issuer(D) | 46K | — | — |
| Aug 1, 2024 | Riedel Norbert G | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Riedel Norbert G | Director | Disposed to issuer(D) | 95K | — | — |
| Aug 1, 2024 | ALTSCHULLER Susan | Chief Financial Officer | Disposed to issuer(D) | 17K | — | — |
| Aug 1, 2024 | ALTSCHULLER Susan | Chief Financial Officer | Disposed to issuer(D) | 81K | — | $0 |
| Aug 1, 2024 | ALTSCHULLER Susan | Chief Financial Officer | Disposed to issuer(D) | 124K | — | — |
| Aug 1, 2024 | Dekkers Marijn E | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Dekkers Marijn E | Director | Disposed to issuer(D) | 32K | — | — |
| Aug 1, 2024 | Dekkers Marijn E | Director | Disposed to issuer(D) | 402K | — | — |
| Aug 1, 2024 | Dekkers Marijn E | Director | Disposed to issuer(D) | 95K | — | — |
| Aug 1, 2024 | Tregoning Kathleen | See Remarks | Disposed to issuer(D) | 11K | — | — |
| Aug 1, 2024 | Tregoning Kathleen | See Remarks | Disposed to issuer(D) | 59K | — | $0 |
| Aug 1, 2024 | Tregoning Kathleen | See Remarks | Disposed to issuer(D) | 614K | — | — |
| Aug 1, 2024 | DiPietro Kenneth | Chief Human Resources Officer | Disposed to issuer(D) | 25K | — | — |
| Aug 1, 2024 | DiPietro Kenneth | Chief Human Resources Officer | Disposed to issuer(D) | 712K | — | — |
| Aug 1, 2024 | DiPietro Kenneth | Chief Human Resources Officer | Disposed to issuer(D) | 64K | — | $0 |
| Aug 1, 2024 | Renger John | Chief Scientific Officer | Disposed to issuer(D) | 6K | — | — |
| Aug 1, 2024 | Renger John | Chief Scientific Officer | Disposed to issuer(D) | 88K | — | $0 |
| Aug 1, 2024 | Renger John | Chief Scientific Officer | Disposed to issuer(D) | 778K | — | — |
| Aug 1, 2024 | Renger John | Chief Scientific Officer | Disposed to issuer(D) | 15K | — | $0 |
| Aug 1, 2024 | Sulzberger Gabrielle | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Sulzberger Gabrielle | Director | Disposed to issuer(D) | 48K | — | — |
| Aug 1, 2024 | Sulzberger Gabrielle | Director | Disposed to issuer(D) | 95K | — | — |
| Aug 1, 2024 | Akamine Scott | Chief Legal Officer | Disposed to issuer(D) | 8K | — | — |
| Aug 1, 2024 | Akamine Scott | Chief Legal Officer | Disposed to issuer(D) | 59K | — | $0 |
| Aug 1, 2024 | Akamine Scott | Chief Legal Officer | Disposed to issuer(D) | 367K | — | — |
| Aug 1, 2024 | Mckernan Ruth | Director | Disposed to issuer(D) | 3K | — | — |
| Aug 1, 2024 | Mckernan Ruth | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Renaud Ronald C JR | President & CEO, Director | Disposed to issuer(D) | 84K | — | — |
| Aug 1, 2024 | Renaud Ronald C JR | President & CEO, Director | Disposed to issuer(D) | 160K | — | — |
| Aug 1, 2024 | Renaud Ronald C JR | President & CEO, Director | Disposed to issuer(D) | 284K | — | $0 |
| Aug 1, 2024 | Renaud Ronald C JR | President & CEO, Director | Disposed to issuer(D) | 321K | — | $0 |
| Aug 1, 2024 | Renaud Ronald C JR | President & CEO, Director | Disposed to issuer(D) | 216K | — | — |
| Aug 1, 2024 | Giordano Douglas E. | Director | Disposed to issuer(D) | 3K | — | — |
| Aug 1, 2024 | Giordano Douglas E. | Director | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Giordano Douglas E. | Director | Disposed to issuer(D) | 95K | — | — |
| Aug 1, 2024 | Sanchez Ramiro | Chief Medical Officer | Disposed to issuer(D) | 15K | — | — |
| Aug 1, 2024 | Sanchez Ramiro | Chief Medical Officer | Disposed to issuer(D) | 1.4M | — | — |
| Aug 1, 2024 | Sanchez Ramiro | Chief Medical Officer | Disposed to issuer(D) | 88K | — | $0 |
| Aug 1, 2024 | Koppel Adam | Director, 10% Owner | Disposed to issuer(D) | 65.7M | — | — |
| Aug 1, 2024 | Koppel Adam | Director, 10% Owner | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Koppel Adam | Director, 10% Owner | Disposed to issuer(D) | 3K | — | — |
| Aug 1, 2024 | Koppel Adam | Director, 10% Owner | Disposed to issuer(D) | 80K | — | — |
| Aug 1, 2024 | Gordon Christopher R | Director, 10% Owner | Disposed to issuer(D) | 65.7M | — | — |
| Aug 1, 2024 | Gordon Christopher R | Director, 10% Owner | Disposed to issuer(D) | 3K | — | — |
| Aug 1, 2024 | Gordon Christopher R | Director, 10% Owner | Disposed to issuer(D) | 10K | — | — |
| Aug 1, 2024 | Gordon Christopher R | Director, 10% Owner | Disposed to issuer(D) | 80K | — | — |
| Aug 1, 2024 | Bain Capital Fund XII, LP | Director, 10% Owner | Disposed to issuer(D) | 65.7M | — | — |
| Jul 1, 2024 | Coles N Anthony | Director | Option exercise(M) | 25K | $3.50 | $88K |
| Jul 1, 2024 | Coles N Anthony | Director | Sell(S) | 25K | $41.18 | $1.0M |
| Jul 1, 2024 | Coles N Anthony | Director | Option exercise(M) | 25K | — | $0 |
| Jun 5, 2024 | Mckernan Ruth | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Sulzberger Gabrielle | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Giordano Douglas E. | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Riedel Norbert G | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Patrick Deval L | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Dekkers Marijn E | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Coles N Anthony | Director | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Koppel Adam | Director, 10% Owner | Grant(A) | 10K | — | — |
| Jun 5, 2024 | Gordon Christopher R | Director, 10% Owner | Grant(A) | 10K | — | — |
| Jun 3, 2024 | Coles N Anthony | Director | Sell(S) | 50K | $40.61 | $2.0M |
| Jun 3, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | $3.50 | $175K |
| Jun 3, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | — | $0 |
| May 10, 2024 | Coles N Anthony | Director | Sell(S) | 50K | $42.10 | $2.1M |
| May 10, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | $3.50 | $175K |
| May 10, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | — | $0 |
| Apr 1, 2024 | Coles N Anthony | Director | Sell(S) | 50K | $42.33 | $2.1M |
| Apr 1, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | $3.50 | $175K |
| Apr 1, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | — | $0 |
| Mar 4, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | $3.50 | $175K |
| Mar 4, 2024 | Coles N Anthony | Director | Sell(S) | 50K | $41.01 | $2.1M |
| Mar 4, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | — | $0 |
| Feb 29, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | $3.50 | $175K |
| Feb 29, 2024 | Coles N Anthony | Director | Sell(S) | 50K | $41.16 | $2.1M |
| Feb 29, 2024 | Coles N Anthony | Director | Option exercise(M) | 50K | — | $0 |
| Feb 20, 2024 | Perceptive Advisors LLC | Director | Gift(G) | 170K | — | $0 |
| Feb 7, 2024 | Coles N Anthony | Director | Sell(S) | 3K | $41.54 | $104K |
| Feb 7, 2024 | Renger John | Chief Scientific Officer | Sell(S) | 2K | $41.54 | $90K |
| Feb 6, 2024 | Coles N Anthony | Director | Option exercise(M) | 15K | — | — |
| Feb 6, 2024 | Coles N Anthony | Director | Option exercise(M) | 15K | — | $0 |
| Feb 6, 2024 | Renger John | Chief Scientific Officer | Option exercise(M) | 5K | — | — |
| Feb 6, 2024 | Renger John | Chief Scientific Officer | Option exercise(M) | 5K | — | $0 |
| Jan 19, 2024 | Akamine Scott | Chief Legal Officer | Grant(A) | 59K | — | $0 |
| Jan 19, 2024 | Renaud Ronald C JR | President & CEO, Director | Grant(A) | 284K | — | $0 |
| Jan 19, 2024 | Sanchez Ramiro | Chief Medical Officer | Grant(A) | 88K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).